Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jennifer Whiteley, Shrividya Iyer, Sean D. Candrilli & James A. Kaye. (2015) Treatment patterns and prognostic indicators of response to therapy among patients with chronic myeloid leukemia in Australia, Canada, and South Korea. Current Medical Research and Opinion 31:2, pages 299-314.
Read now
Read now
Eric Q. Wu, Annie Guerin, Andrew P. Yu, Vamsi K. Bollu, Amy Guo & James D. Griffin. (2010) Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemia. Current Medical Research and Opinion 26:12, pages 2861-2869.
Read now
Read now
Andreas Hochhaus. (2007) Dasatinib for the treatment of Philadelphia chromosome-positive chronic myelogenous leukaemia after imatinib failure. Expert Opinion on Pharmacotherapy 8:18, pages 3257-3264.
Read now
Read now
Andreas Hochhaus. (2007) Management of Bcr–Abl-positive leukemias with dasatinib. Expert Review of Anticancer Therapy 7:11, pages 1529-1536.
Read now
Read now
Articles from other publishers (26)
Larissa V. Furtado, Noah A. Brown & Bryan L. Betz. 2024. Diagnostic Molecular Pathology. Diagnostic Molecular Pathology
569
587
.
Bingbing Wen, Yuming Zhang, Haiqing Lin, Jin Lou, Chuangqing Tu, Yirong Jiang, Xiaolian Liu, Yan Chen, Huiqing He, Zelin Liu, Xiaoling Xie, Wangxiang Huang, Liping Pang & Xin Du. (2023) 18 months follow-up of deep molecular response 4.5 (MR4.5) with nilotinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a prospective, multi-center study in China. Frontiers in Medicine 10.
Crossref
Crossref
Marie Balsat, Vincent Alcazer, Gabriel Etienne, Françoise Huguet, Marc Berger, Emilie Cayssials, Aude Charbonnier, Martine Escoffre-Barbe, Hyacinthe Johnson-Ansah, Laurence Legros, Lydia Roy, Alain Delmer, Jean-Christophe Ianotto, Corentin Orvain, Fabrice Larosa, Mathieu Meunier, Shanti Amé, Annalisa Andreoli, Pascale Cony-Makhoul, Stéphane Morisset, Isabelle Tigaud, Delphine Rea & Franck Emmanuel Nicolini. (2023) First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia. Leukemia Research 130, pages 107308.
Crossref
Crossref
Roseanne Rosario, Wanyuan Cui & Richard A Anderson. (2022) Potential ovarian toxicity and infertility risk following targeted anti-cancer therapies. Reproduction and Fertility 3:3, pages R147-R162.
Crossref
Crossref
Lei Zhong, Yueshan Li, Liang Xiong, Wenjing Wang, Ming Wu, Ting Yuan, Wei Yang, Chenyu Tian, Zhuang Miao, Tianqi Wang & Shengyong Yang. (2021) Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Omid Kiani Ghalesardi, Abbas Khosravi, Ebrahim Azizi, Seyed Esmaeil Ahmadi, Abbas Hajifathali, Hossein Bonakchi & Minoo Shahidi. (2021) The prognostic importance of BCR-ABL transcripts in Chronic Myeloid Leukemia: A systematic review and meta-analysis. Leukemia Research 101, pages 106512.
Crossref
Crossref
Kaichi Nishiwaki, Kei‐ji Sugimoto, Shigehisa Tamaki, Junichi Hisatake, Hisayuki Yokoyama, Tadahiko Igarashi, Atsushi Shinagawa, Takeaki Sugawara, Satoru Hara, Kazuhisa Fujikawa, Seiichi Shimizu, Toshiaki Yujiri, Arinobu Tojo & Hisashi Wakita. (2020)
Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic‐phase chronic myeloid leukemia based on early achievement of deep molecular response (MR
4.5
): The phase 2, multicenter N‐Road study
. Cancer Medicine 9:11, pages 3742-3751.
Crossref
Crossref
Sicília Rezende Oliveira, Luciana Gravito de Azevedo Branco, Amanda Leal Rocha, Denise Vieira Travassos, Gustavo Henrique Romani Magalhães, Felipe Paiva Fonseca, Ricardo Alves Mesquita, Lucas Guimarães Abreu & Tarcília Aparecida da Silva. (2019) Association of oral mucosa hyperpigmentation with imatinib mesylate use: a cross-sectional study and a systematic literature review. Clinical Oral Investigations 23:12, pages 4371-4382.
Crossref
Crossref
Hamideh Kouhpeikar, Alexandra E. Butler, Faeze Bamian, George E. Barreto, Muhammed Majeed & Amirhossein Sahebkar. (2019) Curcumin as a therapeutic agent in leukemia. Journal of Cellular Physiology 234:8, pages 12404-12414.
Crossref
Crossref
Naoto Takahashi, Tetsuzo Tauchi, Kunio Kitamura, Koichi Miyamura, Yoshio Saburi, Yoshihiro Hatta, Yasuhiko Miyata, Shinichi Kobayashi, Kensuke Usuki, Itaru Matsumura, Yosuke Minami, Noriko Usui, Tetsuya Fukuda, Satoru Takada, Maho Ishikawa, Katsumichi Fujimaki, Hiroshi Gomyo, Osamu Sasaki, Kohshi Ohishi, Takaaki Miyake, Kiyotoshi Imai, Hitoshi Suzushima, Hideki Mitsui, Kazuto Togitani, Toru Kiguchi, Yoshiko Atsuta, Shigeki Ohtake, Kazunori Ohnishi, Yukio Kobayashi, Hitoshi Kiyoi, Yasushi Miyazaki & Tomoki Naoe. (2017) Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study. International Journal of Hematology 107:2, pages 185-193.
Crossref
Crossref
Mary Alikian, Robert Peter Gale, Jane F Apperley & Letizia Foroni. (2017) Molecular techniques for the personalised management of patients with chronic myeloid leukaemia. Biomolecular Detection and Quantification 11, pages 4-20.
Crossref
Crossref
N.A. Brown & B.L. Betz. 2017. Diagnostic Molecular Pathology. Diagnostic Molecular Pathology
413
418
.
Marjan Yaghmaie, Mohammad Ahmadvand, Ali-akbar Nejati Safa & Hossein Pashaiefar. 2017. Cancer Genetics and Psychotherapy. Cancer Genetics and Psychotherapy
667
755
.
Mehrdad Payandeh, Masoud Sadeghi & Edris Sadeghi. (2015) Treatment and Survival in Patients with Chronic Myeloid Leukemia in a Chronic Phase in West Iran. Asian Pacific Journal of Cancer Prevention 16:17, pages 7555-7559.
Crossref
Crossref
Michael J. Mauro, Catherine Davis, Teresa Zyczynski & H. Jean Khoury. (2014) The role of observational studies in optimizing the clinical management of chronic myeloid leukemia. Therapeutic Advances in Hematology 6:1, pages 3-14.
Crossref
Crossref
Karim Thomas Sadak, Kara Fultz, Adam Mendizabal, Gregory Reaman, Pat Garcia-Gonzalez & Paul H. Levine. (2014) International patterns of childhood chronic myeloid leukemia: Comparisons between the United States and resource-restricted nations. Pediatric Blood & Cancer 61:10, pages 1774-1778.
Crossref
Crossref
Kevin Marsh, Peng Xu, Panagiotis Orfanos, Agnes Benedict, Kamal Desai & Ingolf Griebsch. (2014) Model-Based Cost-Effectiveness Analyses for the Treatment of Chronic Myeloid Leukaemia: A Review and Summary of Challenges. PharmacoEconomics 32:9, pages 853-864.
Crossref
Crossref
Cheryl-Anne Simoneau. (2013) Treating Chronic Myeloid Leukemia. Clinical Journal of Oncology Nursing 17:1, pages E13-E20.
Crossref
Crossref
D Rea, G Etienne, F Nicolini, P Cony-Makhoul, H Johnson-Ansah, L Legros, F Huguet, M Tulliez, M Gardembas, K Bouabdallah, P Rousselot, J-M Cayuela, F Guilhot & F-X Mahon. (2012) First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia. Leukemia 26:10, pages 2254-2259.
Crossref
Crossref
Lynne Penberthy, Donna McClish, Steven Peace, Laurel Gray, Jim Martin, Sandra Overton, Soundarya Radhakrishnan, Chris Gillam & Gordon Ginder. (2012) Hematologic malignancies: an opportunity to fill a gap in cancer surveillance. Cancer Causes & Control 23:8, pages 1253-1264.
Crossref
Crossref
Patricia S. Ault & Sandra L. Allen-Bard. (2012) Implications of improved survival in patients with chronic myeloid leukemia: a nursing perspective. Community Oncology 9:2, pages 56-64.
Crossref
Crossref
Gulzar Bhat, Ashaqullah Bhat, Aadil Wani, Nida Sadiq, Samoon Jeelani, Rajinder Kaur, Akbar Masood & Bashir Ganai. (2012) Polymorphic Variation in Glutathione-S-transferase Genes and Risk of Chronic Myeloid Leukaemia in the Kashmiri Population. Asian Pacific Journal of Cancer Prevention 13:1, pages 69-73.
Crossref
Crossref
David S. Bosler. 2011. Hematopathology. Hematopathology
215
253
.
Monika Conchon, Carla Maria Boquimpani de Moura Freitas, Maria Aparecida do Carmo Rego & José Wilson Ramos Braga Junior. (2010) Dasatinib. Revista Brasileira de Hematologia e Hemoterapia 33:2, pages 131-139.
Crossref
Crossref
Soley Bayraktar & Mark Goodman. (2010) Detection of BCR-ABL Positive Cells in an Asymptomatic Patient: A Case Report and Literature Review. Case Reports in Medicine 2010, pages 1-3.
Crossref
Crossref
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.